Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
The closing price of CryoPort Inc (NASDAQ: CYRX) was $7.81 for the day, up 5.11% from the previous closing price of $7.43. In other words, the price has increased by $5.11 from its previous closing price. On the day, 0.51 million shares were traded. CYRX stock price reached its highest trading level at $7.9879 during the session, while it also had its lowest trading level at $7.38.
Ratios:
Our analysis of CYRX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.24 and its Current Ratio is at 5.56. In the meantime, Its Debt-to-Equity ratio is 0.61 whereas as Long-Term Debt/Eq ratio is at 0.56.
On March 24, 2025, UBS Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $10.
On December 19, 2024, Guggenheim started tracking the stock assigning a Buy rating and target price of $11.Guggenheim initiated its Buy rating on December 19, 2024, with a $11 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jul 22 ’25 when RAMKUMAR MANDALAM bought 40,728 shares for $6.71 per share.
SHELTON JERRELL sold 16,344 shares of CYRX for $115,366 on Jun 24 ’25. The President, CEO now owns 912,419 shares after completing the transaction at $7.06 per share. On Jun 24 ’25, another insider, Mandalam Ramkumar, who serves as the Director of the company, sold 13,321 shares for $7.01 each. As a result, the insider received 93,447 and left with 73,056 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CYRX now has a Market Capitalization of 391571520 and an Enterprise Value of 426483680. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.82 while its Price-to-Book (P/B) ratio in mrq is 1.08. Its current Enterprise Value per Revenue stands at 1.837 whereas that against EBITDA is -13.069.
Stock Price History:
The Beta on a monthly basis for CYRX is 1.88, which has changed by -0.12834823 over the last 52 weeks, in comparison to a change of 0.17774606 over the same period for the S&P500. Over the past 52 weeks, CYRX has reached a high of $9.77, while it has fallen to a 52-week low of $4.58. The 50-Day Moving Average of the stock is 13.65%, while the 200-Day Moving Average is calculated to be 13.27%.
Shares Statistics:
CYRX traded an average of 475.73K shares per day over the past three months and 379100 shares per day over the past ten days. A total of 50.14M shares are outstanding, with a floating share count of 47.99M. Insiders hold about 4.29% of the company’s shares, while institutions hold 92.08% stake in the company. Shares short for CYRX as of 1751241600 were 2755104 with a Short Ratio of 5.79, compared to 1748563200 on 2516152. Therefore, it implies a Short% of Shares Outstanding of 2755104 and a Short% of Float of 6.54.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
